Gyre Therapeutics Inc (GYRE)

Cash & Short-Term Investments

$74.80M

Quarterly · Period ending: · USD

GYRE logo

GYRE Cash & Short-Term Investments

Latest reported$74.80M
GYRE Quarterly Cash & Short-Term Investments ($24.85M → $74.80M)
High-resolution chart · PNG

GYRE cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Gyre Therapeutics Inc Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
74,796,000
49,808,000
52,425,000
60,049,000
54,365,000
29,891,000
26,671,000
25,092,000
25,100,000
37,352,000
33,509,000
2,228,000
22,166,071
8,099,000
25,175,000
25,175,000
75,394,000
34,817,000
46,851,000
64,528,000
86,523,000
107,000,000
79,354,000
102,882,000
117,364,000
104,528,000
76,865,000
84,950,000
93,935,000
105,277,000
120,127,000
129,221,000
136,146,000
143,518,000
32,443,000
27,450,000
32,388,000
14,533,000
17,064,000
19,525,000
23,950,000
27,667,000
32,498,000
36,761,000
99,774,000
104,759,000
107,385,000
97,916,000
97,715,000
97,245,000
92,329,000
96,756,000
100,197,000
109,839,000
124,961,000
143,700,000
156,478,000
176,558,000
195,004,000
213,480,000
233,183,000
197,318,000
214,022,000
227,981,000
241,076,000
285,090,000
111,066,000
75,311,000
73,112,000
80,238,000
88,363,000
93,747,714
101,920,293
94,251,040
87,039,779
90,356,175
62,996,926
67,785,551
54,189,556
58,785,300
63,488,740
27,200,143
24,851,302
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.